Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Oncology in 2012: from personalized medicine to precision medicine.

× No keyword cloud information.

5 in total

Review 1. Multi-targeted tyrosine kinase inhibitors in clinical development: focus on XL-184 (cabozantinib).

Authors: D W Bowles; E R Kessler; A Jimeno
Journal: Drugs Today (Barc) Date: 2011-11 Impact factor: 2.245

2. Trametinib for patients with advanced melanoma.

Authors: Shigeo Masuda; Juan Carlos Izpisua Belmonte
Journal: Lancet Oncol Date: 2012-10 Impact factor: 41.316

3. Trastuzumab emtansine for HER2-positive advanced breast cancer.

Authors: Sunil Verma; David Miles; Luca Gianni; Ian E Krop; Manfred Welslau; José Baselga; Mark Pegram; Do-Youn Oh; Véronique Diéras; Ellie Guardino; Liang Fang; Michael W Lu; Steven Olsen; Kim Blackwell
Journal: N Engl J Med Date: 2012-10-01 Impact factor: 91.245

Review 4. Targeting regulatory T cells.

Authors: Christine Ménétrier-Caux; Tyler Curiel; Julien Faget; Manuarii Manuel; Christophe Caux; Weiping Zou
Journal: Target Oncol Date: 2012-02-12 Impact factor: 4.493

Review 5. Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma.

Authors: Andres Morales La Madrid; Andres Morales La Madrid; Nicholas Campbell; Sonali Smith; Susan L Cohn; Ravi Salgia
Journal: Target Oncol Date: 2012-09-12 Impact factor: 4.493

5 in total